1. Home
  2. ETWO vs TRML Comparison

ETWO vs TRML Comparison

Compare ETWO & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETWO
  • TRML
  • Stock Information
  • Founded
  • ETWO 2000
  • TRML 2021
  • Country
  • ETWO United States
  • TRML United States
  • Employees
  • ETWO N/A
  • TRML N/A
  • Industry
  • ETWO EDP Services
  • TRML Biotechnology: Pharmaceutical Preparations
  • Sector
  • ETWO Technology
  • TRML Health Care
  • Exchange
  • ETWO Nasdaq
  • TRML Nasdaq
  • Market Cap
  • ETWO 621.8M
  • TRML 509.8M
  • IPO Year
  • ETWO N/A
  • TRML N/A
  • Fundamental
  • Price
  • ETWO $1.91
  • TRML $13.12
  • Analyst Decision
  • ETWO Sell
  • TRML Strong Buy
  • Analyst Count
  • ETWO 4
  • TRML 6
  • Target Price
  • ETWO $3.13
  • TRML $45.20
  • AVG Volume (30 Days)
  • ETWO 935.7K
  • TRML 377.3K
  • Earning Date
  • ETWO 04-29-2025
  • TRML 05-12-2025
  • Dividend Yield
  • ETWO N/A
  • TRML N/A
  • EPS Growth
  • ETWO N/A
  • TRML N/A
  • EPS
  • ETWO N/A
  • TRML N/A
  • Revenue
  • ETWO $613,459,000.00
  • TRML N/A
  • Revenue This Year
  • ETWO N/A
  • TRML $363.93
  • Revenue Next Year
  • ETWO $1.84
  • TRML N/A
  • P/E Ratio
  • ETWO N/A
  • TRML N/A
  • Revenue Growth
  • ETWO N/A
  • TRML N/A
  • 52 Week Low
  • ETWO $1.86
  • TRML $11.87
  • 52 Week High
  • ETWO $5.08
  • TRML $29.79
  • Technical
  • Relative Strength Index (RSI)
  • ETWO 32.99
  • TRML 34.27
  • Support Level
  • ETWO $1.95
  • TRML $16.39
  • Resistance Level
  • ETWO $2.09
  • TRML $17.36
  • Average True Range (ATR)
  • ETWO 0.12
  • TRML 1.11
  • MACD
  • ETWO -0.02
  • TRML -0.46
  • Stochastic Oscillator
  • ETWO 8.32
  • TRML 9.76

About ETWO E2open Parent Holdings Inc.Class A

E2open Parent Holdings Inc is an end-to-end and cloud-based supply chain management SaaS platform. The company's software combines networks, data, and applications to provide a deeply embedded, mission-critical platform that allows customers to optimize the supply chain across channel shaping, business planning, logistics, trade, manufacturing, and supply management. The Group has one reportable segment consisting of cloud-based, end-to-end SCM software. Geographically, the company operates in the Americas, Europe, and Asia Pacific, out of which the majority is from the Americas.

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

Share on Social Networks: